Showing results (1691-1700 of 1,799) with videos related to

Sort By:
Pageof 180
Mabs|January 7, 2026
Multidimensional maturation of antibody variable domains with machine-learning assistanceTomoyuki Ito, Sakiya Kawada, Hikaru Nakazawa, et al.
Mabs|January 9, 2026
Systematic characterization of lysine glucuronidation in a bispecific antibodyMichael R Reyda, Qinqin Ji, Maggie Huang, et al.
Mabs|December 22, 2025
Structure-guided design of antibody CDRs to reduce their reactivity to treatment-emergent anti-drug antibodiesMaria U Johansson, Anne Kerschenmeyer, Alessandra Carella, et al.
Mabs|November 5, 2025
From discovery to the clinic: structural insights, engineering options, clinical, and 'next wave' applications of camelid-derived single-domain antibodiesAndreas Evers, Enrico Guarnera, Lukas Pekar, et al.
Mabs|November 5, 2025
Integrating computational simulation and high-throughput screening for the development of robust ultra-high concentration formulation of IgG1 antibodyChen Lyu, Shuyan Lu, Yiqiu Yin, et al.
Mabs|October 22, 2025
Bi-functional integrin degraders cause stronger anti-proliferative effects than a blocking antibody by modulating distinct downstream signalingMeghan F Monroy, Megan Krumpoch, T Andrew McTeague, et al.
Mabs|October 30, 2025
Monoclonal antibody formulations: a quantitative analysis of marketed products and patentsYixuan Peng, Liyang Lyu, Shiyun Chen, et al.
Mabs|October 19, 2025
IL-17A complexes with therapeutic antibodies exhibit distinct size distributions, potentially contributing to clinically observed immunogenicityDennis Ungan, Céline Be, Paulina Baczyk, et al.
Mabs|October 17, 2025
Germline-aware deep learning models and benchmarks for predicting antibody VH-VL pairingSara Joubbi, Enrico D'Arco, Giuseppe Maccari, et al.
Mabs|October 13, 2025
Immunogenicity of single-chain antibodies: germlining of a VHH lowers T-cell activation from epitopes in FR2 and CDR regionsRemi Giraudet, Adrien Laroche, Benjamin Chalopin, et al.
Pageof 180